– the leading provider of online annual reports to individual and institutional investors.

Dendreon Corp.

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports